John Stephen Lazo

Prof. John Stephen Lazo


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Ruben Manuel Luciano Colunga BiancatelliRuben Manuel Luciano Colunga Biancatelli
Ruben Manuel Luciano Colunga Biancatelli
Pavel A. SolopovPavel A. Solopov
Pavel A. Solopov
TDTierney Day
Tierney Day
AYAlicia Yu-Shan
Alicia Yu-Shan
CMConnor Meek
Connor Meek
JCJohn Catravas
John Catravas
Mechanical ventilation is a life-saving intervention in acute respiratory failure but can precipitate venti-lator-induced lung injury (VILI) through volutrauma, barotrauma, and biotrauma. In this study, we hypothesized that intravenous injection of KVX-053, a protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) inhibitor, could mitigate lung injury following high tidal ventilation (HTV). Male and female mice were anesthetized with ketamine/xylazine mix (20-50 mg/kg and 3-5 mg/kg), connected to a FlexiVent small animal ventilator (SCIREQ) and ventilated at standard tidal ventilation (STV, 10 mL/Kg) or HTV (30 mL/Kg) for 4 hours. Two additional groups were subjected to HTV and received KVX-053 (1 mg/kg iv) either 30 minutes before or after the beginning of the ventilation. During ventilation, a complete set of respiratory parameters was collected hourly. After 4 hours, mice were euthanized, bronchoalveolar lavage fluid collected for cellularity and cytokine/chemokine expression and lungs harvested for wet-to-dry ratio, molecular and histological analyses. KVX-053 preserved dynamic and static compli-ances (Cst/Crs), attenuated HTV-induced increases in respiratory resistances (Rrs, G, Ers), reduced al-veolar cellularity and proteinosis, lowered wet-to-dry lung weight ratios, and improved histological ar-chitecture. Furthermore, KVX-053 suppressed STAT3 and IκBα phosphorylation, prevented the HTV-mediated cytokine surge involving IL-1/TNF, IFN-γ axis mediators, IL-2/IL-15, Th2, and Th17, restored SHP-2 expression, decreased TGF-β1 mRNA levels, and normalized VEGF expression toward control values. These findings indicate that KVX-053 administered iv at 1 mg/kg did not produce ob-servable acute adverse effects and, in both pre- and post-treatment paradigms, mitigated both biotrauma and volutrauma following HTV.